Fortrea Holdings (FTRE) Exchange Rate Effect (2022 - 2026)
Fortrea Holdings (FTRE) reported Exchange Rate Effect of -$2.1 million for Q1 2026, down 175.0% on a YoY basis from $2.8 million in Q1 2025, and up 19.23% quarter-over-quarter from -$2.6 million in Q4 2025.
Fortrea Holdings (FTRE) Exchange Rate Effect (2022 - 2026) Analysis & Trends
Fortrea Holdings has reported Exchange Rate Effect for 5 years, with the latest figure at -$2.1 million in Q1 2026.
- For the quarter ending Q1 2026, Exchange Rate Effect fell 175.0% year-over-year to -$2.1 million; the trailing twelve-month figure through Mar 2026 stood at -$400000.0 (up 75.0% YoY), and the FY2025 full-year result was $4.5 million, up 167.16% from the prior year.
- Exchange Rate Effect for Q1 2026 stood at -$2.1 million, up from -$2.6 million in the prior quarter.
- The five-year high for Exchange Rate Effect was $4.3 million in Q2 2025, with the low at -$6.3 million in Q4 2024.
- Historically, Exchange Rate Effect has averaged -$264285.7 across 5 years, with a median of -$950000.0 in 2023.
- Annual changes were most pronounced in 2024 — Exchange Rate Effect plunged 750.0% — and 2025, when it soared 352.94%.
- Fortrea Holdings' Exchange Rate Effect stood at $3.7 million in 2022, then declined by 16.22% to $3.1 million in 2023, then plunged by 303.23% to -$6.3 million in 2024, then soared by 58.73% to -$2.6 million in 2025, then grew by 19.23% to -$2.1 million in 2026.
- The last three Exchange Rate Effect figures came in at -$2.1 million (Q1 2026), -$2.6 million (Q4 2025), and $4.3 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 8.68 Mn |
| 10 | Fortrea Holdings | 1.43 Bn | 1.28 Bn | 123.60 Mn | -2.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.10 Mn |
| Mar 31, 2026 | -2.10 Mn |
| Dec 31, 2025 | -2.60 Mn |
| Dec 31, 2025 | -2.60 Mn |
| Jun 30, 2025 | 4.30 Mn |
| Jun 30, 2025 | 4.30 Mn |
| Mar 31, 2025 | 2.80 Mn |
| Mar 31, 2025 | 2.80 Mn |
| Dec 31, 2024 | -6.30 Mn |
| Dec 31, 2024 | -6.30 Mn |
| Sep 30, 2024 | 3.60 Mn |
| Sep 30, 2024 | 3.60 Mn |
| Jun 30, 2024 | -1.70 Mn |
| Jun 30, 2024 | -1.70 Mn |
| Mar 31, 2024 | -2.30 Mn |
| Mar 31, 2024 | -2.30 Mn |
| Dec 31, 2023 | 3.10 Mn |
| Dec 31, 2023 | 3.10 Mn |
| Sep 30, 2023 | -2.00 Mn |
| Sep 30, 2023 | -2.00 Mn |